Edwards Lifesciences Tangible Asset Value Trend

EW -- USA Stock  

USD 149.81  0.61  0.41%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Tangible Asset Value of Edwards Lifesciences Corporation with missing and latest data points interpolated. The value of tangibles assets calculated as the difference between Total Assets and Goodwill and Intangible Assets.
Tangible Asset Value10 Years Trend
Increasing
Slightly volatile
 Tangible Asset Value 
      Timeline 

Regression Statistics

Arithmetic Mean  2,260,672,807
Geometric Mean  1,950,052,354
Coefficient Of Variation  50.98
Mean Deviation  1,010,639,474
Median  2,291,000,000
Standard Deviation  1,152,475,532
Range  3,098,600,000
R Value  0.98
R Squared  0.96
Significance  0.00000004
Slope  312,737,100

Edwards Lifesciences Tangible Asset Value Over Time

2016-12-31  3,679,100,000 
2017-12-31  3,679,100,000 
2018-12-31  3,632,473,684 

Other Fundumenentals

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Edwards Lifesciences Upcoming Company Events

Upcoming Quarterly ReportApril 25, 2017
Next Earnings ReportJuly 25, 2017
Additionally see analysis of Edwards Lifesciences Correlation with competitors. Please also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.